- $18.02bn
- $17.50bn
- KZT3.12tn
Kaspi.kz's US-listed shares rise after Q1 profit jumps
Brief: Kazakhstan's Kaspi.Kz Q1 profit up 28% y/y
Kaspi.kz to cancel London listing as it moves to NASDAQ
JSC Kaspi.kz - Notice of AGM of Shareholders of Kaspi.kz
Brief: Kazakh fintech Kaspi.kz Q4 profit jumps 32% y/y
JSC Kaspi.kz - Kaspi.kz 4Q & FY 2023 Financial Results
JSC Kaspi.kz - Kaspi.kz to Announce 4Q & FY2023 Financial Results
JSC Kaspi.kz - Director/PDMR Shareholding
Drug developer CG Oncology targets up to $306 mln for upsized IPO (updated)
Kaspi.kz commands $17.5 bln valuation in Nasdaq debut (updated)
Kaspi.kz commands $17.5 bln valuation in Nasdaq debut
Brief: Kaspi.kz AO Announces Pricing Of Upsized U.S IPO At A Price Of $92.00 Per ADS
JSC Kaspi.kz - Kaspi.kz Amends Deposit Agreement
Kazakh fintech company Kaspi.kz prices US share offering
Media: Mobile app Kaspi.kz's U.S. IPO raises $1 bln for investors- Bloomberg News
Brief: KASPI.KZ AO Says Termination Of GDR Repurchase Programme
Brief: Kaspi.kz to launch U.S. share offering
Kazakh fintech giant Kaspi.kz makes US IPO filing public (updated)
Kazakhstan-based fintech Kaspi.kz makes US IPO filing public